1,336
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Marginal role of von Willebrand factor-binding protein and coagulase in the initiation of endocarditis in rats with catheter-induced aortic vegetations

, , , , , , , ORCID Icon, , , & ORCID Icon show all
Pages 1615-1624 | Received 01 Jun 2018, Accepted 18 Sep 2018, Published online: 13 Oct 2018

References

  • Que YA, Moreillon P. Infective endocarditis. Nat Rev Cardiol. 2011;8:322–336.
  • Holland TL, Baddour LM, Bayer AS, et al. Infective endocarditis. Nature Rev Dis Prim. 2016;2:16059.
  • Weidenmaier C, Peschel A, Xiong YQ, et al. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis. 2005;191:1771–1777.
  • Que YA, Haefliger JA, Piroth L, et al. Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med. 2005;201:1627–1635.
  • Widmer E, Que YA, Entenza JM, et al. New concepts in the pathophysiology of infective endocarditis. Curr Infect Dis Rep. 2006;8:271–279.
  • Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun. 1995;63:4738–4743.
  • Que YA, Francois P, Haefliger JA, et al. Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis. Infect Immun. 2001;69:6296–6302.
  • Sinha B, Francois P, Que YA, et al. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun. 2000;68:6871–6878.
  • Heying R, van de Gevel J, Que YA, et al. Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: fnBPA is sufficient to activate human endothelial cells. Thromb Haaemost. 2007;97:617–626.
  • Piroth L, Que YA, Widmer E, et al. The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis. Infect Immun. 2008;76:3824–3831.
  • Friedrich R, Panizzi P, Fuentes-Prior P, et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 2003;425:535–539.
  • Bjerketorp J, Jacobsson K, Frykberg L. The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett. 2004;234:309–314.
  • Vanassche T, Kauskot A, Verhaegen J, et al. Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation. Thromb Haemost. 2012;107:1107–1121.
  • McAdow M, Missiakas DM, Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun. 2012;4:141–148.
  • Thomer L, Schneewind O, Missiakas D. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. J Biol Chem. 2013;288:28283–28292.
  • Cheng AG, McAdow M, Kim HK, et al. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathogens. 2010;6:e1001036.
  • Vanassche T, Verhaegen J, Peetermans WE, et al. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost. 2011;9:2436–2446.
  • Claes J, Vanassche T, Peetermans M, et al. Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein. Blood. 2014;124:1669–1676.
  • Loof TG, Goldmann O, Naudin C, et al. Staphylococcus aureus-induced clotting of plasma is an immune evasion mechanism for persistence within the fibrin network. Microbiology. 2015;161:621–627.
  • Baddour LM, Tayidi MM, Walker E, et al. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J Med Microbiol. 1994;41:259–263.
  • Stutzmann Meier P, Entenza JM, Vaudaux P, et al. Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect Immun. 2001;69:657–664.
  • Panizzi P, Nahrendorf M, Figueiredo JL, et al. In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nature Med. 2011;17:1142–1146.
  • Heilmann C, Herrmann M, Kehrel BE, et al. Platelet-binding domains in 2 fibrinogen-binding proteins of Staphylococcus aureus identified by phage display. J Infect Dis. 2002;186:32–39.
  • McDevitt D, Vaudaux P, Foster TJ. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect Immun. 1992;60:1514–1523.
  • Bayer AS, Ramos MD, Menzies BE, et al. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun. 1997;65:4652–4660.
  • Kupferwasser LI, Yeaman MR, Shapiro SM, et al. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation. 2002;105:746–752.
  • Mercier RC, Dietz RM, Mazzola JL, et al. Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis. Antimicrob Agents Chemother. 2004;48:2551–2557.
  • Loof TG, Morgelin M, Johansson L, et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood. 2011;118:2589–2598.
  • Papareddy P, Rydengard V, Pasupuleti M, et al. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathogens. 2010;6:e1000857.
  • Lebeau C, Vandenesch F, Greenland T, et al. Coagulase expression in Staphylococcus aureus is positively and negatively modulated by an agr-dependent mechanism. J Bacteriol. 1994;176:5534–5536.
  • Claes J, Liesenborghs L, Peetermans M, et al. Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall. J Thromb Haemost. 2017;15:1009–1016.
  • Liesenborghs L, Peetermans M, Claes J, et al. Shear-resistant binding to von Willebrand factor allows Staphylococcus lugdunensis to adhere to the cardiac valves and initiate endocarditis. J Infect Dis. 2016;213:1148–1156.
  • Keuren JF, Baruch D, Legendre P, et al. von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate. Blood. 2004;103:1741–1746.
  • Miszta A, Pelkmans L, Lindhout T, et al. Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network. J Biol Chem. 2014;289:35979–35986.
  • Grundmeier M, Hussain M, Becker P, et al. Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun. 2004;72:7155–7163.
  • Stojanov M, Sakwinska O, Moreillon P. Expression of SCCmec cassette chromosome recombinases in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. J Antimicrob Chemother. 2013;68:749–757.
  • Que YA, Haefliger JA, Francioli P, et al. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun. 2000;68:3516–3522.
  • Holo H, Nes IF. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol. 1989;55:3119–3123.
  • Vanassche T, Verhaegen J, Peetermans WE, et al. Dabigatran inhibits Staphylococcus aureus coagulase activity. J Clin Microbiol. 2010;48:4248–4250.
  • Veloso TR, Que YA, Chaouch A, et al. Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? J Infect Dis. 2015;211:72–79.
  • Heraief E, Glauser MP, Freedman LR. Natural history of aortic valve endocarditis in rats. Infect Immun. 1982;37:127–131.